Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
about
Heme-dependent and independent soluble guanylate cyclase activators and vasodilation.Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide.Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
P2860
Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@en
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@nl
type
label
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@en
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@nl
prefLabel
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@en
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@nl
P2093
P2860
P1476
Effect of BAY 41-2272 in the p ...... complex in anaesthetized dogs.
@en
P2093
Cristiane F Freitas
Joyce M Annichino-Bizzacchi
Rafael P Morganti
P2860
P356
10.1111/J.1440-1681.2007.04524.X
P577
2007-01-01T00:00:00Z